Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

EOMES interacts with RUNX3 and BRG1 to promote innate memory cell formation through epigenetic reprogramming.

Istaces N, Splittgerber M, Lima Silva V, Nguyen M, Thomas S, Le A, Achouri Y, Calonne E, Defrance M, Fuks F, Goriely S, Azouz A.

Nat Commun. 2019 Jul 24;10(1):3306. doi: 10.1038/s41467-019-11233-6.

2.

Selective cyclooxygenase inhibition and ulcerogenic liability of some newly prepared anti-inflammatory agents having thiazolo[4,5-d]pyrimidine scaffold.

Bakr RB, Ghoneim AA, Azouz AA.

Bioorg Chem. 2019 Jul;88:102964. doi: 10.1016/j.bioorg.2019.102964. Epub 2019 Apr 30.

PMID:
31075742
3.

Hepatoprotective effects of diosmin and/or sildenafil against cholestatic liver cirrhosis: The role of Keap-1/Nrf-2 and P38-MAPK/NF-κB/iNOS signaling pathway.

Ali FEM, Azouz AA, Bakr AG, Abo-Youssef AM, Hemeida RAM.

Food Chem Toxicol. 2018 Oct;120:294-304. doi: 10.1016/j.fct.2018.07.027. Epub 2018 Jul 17.

PMID:
30026087
4.

Targeting Keap-1/Nrf-2 pathway and cytoglobin as a potential protective mechanism of diosmin and pentoxifylline against cholestatic liver cirrhosis.

Ali FEM, Bakr AG, Abo-Youssef AM, Azouz AA, Hemeida RAM.

Life Sci. 2018 Aug 15;207:50-60. doi: 10.1016/j.lfs.2018.05.048. Epub 2018 May 28.

PMID:
29852187
5.

Design, synthesis, analgesic, anti-inflammatory activity of novel pyrazolones possessing aminosulfonyl pharmacophore as inhibitors of COX-2/5-LOX enzymes: Histopathological and docking studies.

Abdelgawad MA, Labib MB, Ali WAM, Kamel G, Azouz AA, El-Nahass ES.

Bioorg Chem. 2018 Aug;78:103-114. doi: 10.1016/j.bioorg.2018.03.011. Epub 2018 Mar 8.

PMID:
29550530
6.

The transcription factors Runx3 and ThPOK cross-regulate acquisition of cytotoxic function by human Th1 lymphocytes.

Serroukh Y, Gu-Trantien C, Hooshiar Kashani B, Defrance M, Vu Manh TP, Azouz A, Detavernier A, Hoyois A, Das J, Bizet M, Pollet E, Tabbuso T, Calonne E, van Gisbergen K, Dalod M, Fuks F, Goriely S, Marchant A.

Elife. 2018 Feb 28;7. pii: e30496. doi: 10.7554/eLife.30496.

7.

Novel pyrimidine-pyridine hybrids: Synthesis, cyclooxygenase inhibition, anti-inflammatory activity and ulcerogenic liability.

Abdelgawad MA, Bakr RB, Azouz AA.

Bioorg Chem. 2018 Apr;77:339-348. doi: 10.1016/j.bioorg.2018.01.028. Epub 2018 Jan 31.

PMID:
29421710
8.

Corrigendum to "Synthesis and biological evaluations of new nitric oxide-anti-inflammatory drug hybrids" [Bioorg Med Chem Lett (2017) 4358-4369].

Abdelall EKA, Abdelhamid AO, Azouz AA.

Bioorg Med Chem Lett. 2018 Feb 15;28(4):839. doi: 10.1016/j.bmcl.2018.01.024. Epub 2018 Jan 31. No abstract available.

PMID:
29395977
9.

Discovery of a COX-2 selective inhibitor hit with anti-inflammatory activity and gastric ulcer protective effect.

Abdelgawad MA, Bakr RB, El-Gendy AO, Kamel GM, Azouz AA, Bukhari SNA.

Future Med Chem. 2017 Oct;9(16):1899-1912. doi: 10.4155/fmc-2017-0115. Epub 2017 Oct 27.

PMID:
29076755
10.

Synthesis and biological evaluations of new nitric oxide-anti-inflammatory drug hybrids.

Abdelall EKA, Abdelhamid AO, Azouz AA.

Bioorg Med Chem Lett. 2017 Sep 15;27(18):4358-4369. doi: 10.1016/j.bmcl.2017.08.023. Epub 2017 Aug 13. Erratum in: Bioorg Med Chem Lett. 2018 Jan 27;:.

PMID:
28844389
11.

Novel tetrazole and cyanamide derivatives as inhibitors of cyclooxygenase-2 enzyme: design, synthesis, anti-inflammatory evaluation, ulcerogenic liability and docking study.

Lamie PF, Philoppes JN, Azouz AA, Safwat NM.

J Enzyme Inhib Med Chem. 2017 Dec;32(1):805-820. doi: 10.1080/14756366.2017.1326110.

12.

Synthesis, anti-inflammatory, cyclooxygenases inhibitions assays and histopathological study of poly-substituted 1,3,5-triazines: Confirmation of regiospecific pyrazole cyclization by HMBC.

Elshemy HAH, Abdelall EKA, Azouz AA, Moawad A, Ali WAM, Safwat NM.

Eur J Med Chem. 2017 Feb 15;127:10-21. doi: 10.1016/j.ejmech.2016.12.030. Epub 2016 Dec 23.

PMID:
28038322
13.

Synthesis, Cyclooxygenase Inhibition, Anti-Inflammatory Evaluation, and Ulcerogenic Liability of New 1,3,5-Triarylpyrazoline Derivatives Possessing a Methanesulfonyl Pharmacophore.

Abdellatif KR, Fadaly WA, Azouz AA.

Arch Pharm (Weinheim). 2016 Oct;349(10):801-807. doi: 10.1002/ardp.201600145. Epub 2016 Sep 7.

PMID:
27601359
14.

Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1-phenylpyrazolo[3,4-d]pyrimidine derivatives.

Bakr RB, Azouz AA, Abdellatif KR.

J Enzyme Inhib Med Chem. 2016;31(sup2):6-12. Epub 2016 May 22.

PMID:
27210522
15.

Type I interferons regulate eomesodermin expression and the development of unconventional memory CD8(+) T cells.

Martinet V, Tonon S, Torres D, Azouz A, Nguyen M, Kohler A, Flamand V, Mao CA, Klein WH, Leo O, Goriely S.

Nat Commun. 2015 May 8;6:7089. doi: 10.1038/ncomms8089.

16.

Advances in three-dimensional rapid prototyping of microfluidic devices for biological applications.

O'Neill PF, Ben Azouz A, Vázquez M, Liu J, Marczak S, Slouka Z, Chang HC, Diamond D, Brabazon D.

Biomicrofluidics. 2014 Oct 16;8(5):052112. doi: 10.1063/1.4898632. eCollection 2014 Sep.

17.

Focussed ion beam serial sectioning and imaging of monolithic materials for 3D reconstruction and morphological parameter evaluation.

Vázquez M, Moore D, He X, Ben Azouz A, Nesterenko E, Nesterenko P, Paull B, Brabazon D.

Analyst. 2014 Jan 7;139(1):99-104. doi: 10.1039/c3an01827j. Epub 2013 Oct 25.

PMID:
24157809
18.

Breast lymphoma complicating anti-tumor necrosis factor therapy in rheumatoid arthritis.

Pattanaik D, Koduru S, Azouz A, Patil S, Carbone L.

Clin Breast Cancer. 2011 Dec;11(6):413-6. doi: 10.1016/j.clbc.2011.01.001. Epub 2011 May 12.

PMID:
21729669
19.

Epigenetic plasticity of hTERT gene promoter determines retinoid capacity to repress telomerase in maturation-resistant acute promyelocytic leukemia cells.

Azouz A, Wu YL, Hillion J, Tarkanyi I, Karniguian A, Aradi J, Lanotte M, Chen GQ, Chehna M, Ségal-Bendirdjian E.

Leukemia. 2010 Mar;24(3):613-22. doi: 10.1038/leu.2009.283. Epub 2010 Jan 14.

PMID:
20072159
20.

Functional involvement of RINF, retinoid-inducible nuclear factor (CXXC5), in normal and tumoral human myelopoiesis.

Pendino F, Nguyen E, Jonassen I, Dysvik B, Azouz A, Lanotte M, Ségal-Bendirdjian E, Lillehaug JR.

Blood. 2009 Apr 2;113(14):3172-81. doi: 10.1182/blood-2008-07-170035. Epub 2009 Jan 30.

PMID:
19182210
21.

Hepatic colorectal cancer metastases: imaging initial steps of formation in mice.

Kruskal JB, Azouz A, Korideck H, El-Hallak M, Robson SC, Thomas P, Goldberg SN.

Radiology. 2007 Jun;243(3):703-11. Epub 2007 Apr 12.

PMID:
17431127
22.

Juvenile-onset loss of lipid-raft domains in attractin-deficient mice.

Azouz A, Gunn TM, Duke-Cohan JS.

Exp Cell Res. 2007 Feb 15;313(4):761-71. Epub 2006 Dec 6.

PMID:
17196964
23.

Immunoinflammatory responses and fibrogenesis.

Azouz A, Razzaque MS, El-Hallak M, Taguchi T.

Med Electron Microsc. 2004 Sep;37(3):141-8. Review.

PMID:
15449105
24.

Attractin: cautionary tales for therapeutic intervention in molecules with pleiotropic functionality.

Duke-Cohan JS, Kim JH, Azouz A.

J Environ Pathol Toxicol Oncol. 2004;23(1):1-11. Review.

PMID:
14994991
25.

Factors regulating the progression of hypertensive nephrosclerosis.

Razzaque MS, Azouz A, Shinagawa T, Taguchi T.

Contrib Nephrol. 2003;139:173-86. Review. No abstract available.

PMID:
12854325
26.

SKAP-55 regulates integrin adhesion and formation of T cell-APC conjugates.

Wang H, Moon EY, Azouz A, Wu X, Smith A, Schneider H, Hogg N, Rudd CE.

Nat Immunol. 2003 Apr;4(4):366-74. Epub 2003 Mar 24.

PMID:
12652296
27.
28.

[The incidence of locoregional recurrences of breast cancer after surgery and radiation].

Schertel L, Mohring R, Azouz A.

Rontgenpraxis. 1992 Jun;45(6):191-5. German. No abstract available.

PMID:
1322562

Supplemental Content

Support Center